Leadiant Hit By Second Complaint Over Price Of CTX Drug In Europe

 
• By Ian Schofield
  
MoneyPill
The price of Leadiant's CTX drug is again under scrutiny • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography